Search tips
Search criteria 


Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2012; 7(7): e41373.
Published online 2012 July 19. doi:  10.1371/journal.pone.0041373
PMCID: PMC3400627

TH17, TH22 and TReg Cells Are Enriched in the Healthy Human Cecum

Padraic G. Fallon, Editor


There is increasing evidence that dysregulation of CD4+ T cell populations leads to intestinal inflammation, but the regional distribution of these populations throughout the intestinal tract in healthy individuals remains unclear. Here, we show that TH17, TH22 and TReg cells are enriched in the healthy human cecum compared to the terminal ileum and sigmoid colon, whereas TH1 and TH2 cells do not significantly vary by location. Transcriptional profiling analysis of paired pinch biopsies from different regions of the intestine identified significant differences in the metabolic state of the terminal ileum, cecum, and sigmoid colon. An increased proportion of TH17 cells was positively associated with expression of resistin (RETN) and negatively associated with expression of trefoil factor 1 (TFF1). These results suggest that CD4+ T helper cells that are important in maintaining mucosal barrier function may be enriched in the cecum as a result of metabolic differences of the surrounding microenvironment.


The human intestinal epithelium represents a critical interface between our entire internal milieu and the outside world [1]. Appropriate mucosal homeostasis depends on interaction between the commensal microbiota, the intestinal epithelium, and the mucosal immune system [2]. Of mucosal immune cells, TH17 cells are particularly important in regulating intestinal immunity and have a complex role in human disease [1], [2]. For example, TH17 cells have been shown to be increased in active Crohn's disease [3] and are reduced in HIV infection [4]. Induced FoxP3+ regulatory T cells (TRegs) are developmentally linked to TH17 cells, with both requiring TGFβ for differentiation [5]. Recent evidence suggests that these two cell populations may arise from the same naïve precursor cells and exhibit plasticity [6]. For example, FoxP3+IL-17+ CD4+ cells have now been observed under several different inflammatory conditions [7], [8]. One of the cytokines produced by TH17 cells that is important in regulating mucosal barrier function is IL-22, which has been shown to promote epithelial proliferation and increase mucus production [9]. Not all TH17 cells produce IL-22, however, and a subset of CD4+ helper T cells that produce IL-22 but not IL-17 have been identified in humans and are termed TH22 cells [10]. While these different CD4+ T cell populations have been suggested to play important roles in regulating intestinal immunity, their exact functions in inflammation during human disease remain unclear, perhaps because an appropriate balance of these cells is required for healthy homeostasis.

In order to better understand how dysregulation among populations of CD4+ T cells in the intestinal lamina propria may be important during inflammatory conditions of the gastrointestinal tract, it is necessary to fully characterize these populations in healthy individuals. Specifically, the regional variations of these lymphocyte populations within the small and large intestine may provide important clues to their function in vivo. In order to address this question, we analyzed mucosal pinch biopsies collected from the terminal ileum (TI), ileocecal valve (ICV), appendiceal orifice (AO), and sigmoid colon (SC) from a healthy population presenting for screening colonoscopy. We were particularly interested in evaluating the cecal appendix given its implication in a number of inflammatory and infectious disease states, including ulcerative colitis and Clostridium difficile infection [11], [12]. Here we report that the proximal colon (cecum) is enriched in TH17, TH22, and TReg (but not TH1 or TH2) cell populations compared to the terminal ileum and distal large intestine in healthy individuals. We hypothesize that these differences are related to variations in metabolism and immune activation among different regions of the colon and small intestine.


TH17 and TReg cells are enriched in the healthy human cecum

Different regions of the intestinal tract perform diverse dietary functions and are colonized with distinct concentrations of commensal bacteria [13]. We therefore hypothesized that there are important differences in the distribution of lymphocyte populations in the healthy human gut. Based on mounting evidence of the immunologic function of the human cecum [12], [14], our objective was to characterize the distribution of CD4+ T helper cell populations in the cecum relative to the terminal ileum and sigmoid colon in healthy individuals. We recruited 26 unique patients at average-risk for colon cancer who were undergoing screening colonoscopy and consented to participate in this study (Table 1). The majority of the subjects were black men with an average age of 58.9+6.2 (Table 1) and therefore may not be representative for other gender, age, and ethnic groups. Hematologic and renal function parameters were within normal range for the majority of subjects. As shown in Table 2, the prevalence of adenomatous polyp tissue obtained at colonoscopy in this cohort (30.7%) is typical of the average prevalence in the age-adjusted general population [15].

Table 1
Characteristics of the study population.
Table 2
Endoscopic findings and pathologic diagnoses at screening colonoscopy.

To assess regional differences in CD4+ T helper cell populations, lamina propria mononuclear cells (LPMCs) were isolated from pinch biopsies obtained at the terminal ileum (TI), ileocecal valve (ICV), appendiceal orifice (AO), and the sigmoid colon (SC). The ICV and AO are anatomical landmarks of the most proximal portion of the large intestine (i.e. the cecum). We were particularly interested in comparing immune parameters of the cecum with the TI because it is a critical site of luminal sampling and is rich in mucosal associated lymphoid tissue [16]. Biopsies were additionally taken from the SC (defined arbitrarily as 20cm from the anal verge in all subjects), because it represents a hindgut-derived distal site in the human colon that is easily accessible in all subjects. Biopsy-derived LPMCs were stimulated with phorbol 12- myristate 13-acetate (PMA) and ionomycin and then assessed for a number of immune markers by polychromatic flow cytometry. The flow cytometry panels used for this analysis are shown in Tables 3 and and4.4. By gating on singlet, live, CD3+ CD4+ T cells (Figure 1A), we compared the frequency of IL-17 producing CD4+ cells among different regions of the small and large intestine (Figure 1B). There was a significantly elevated frequency (Figure 1C) of IL-17 producing CD4+ cells in both parts of the cecum including the ICV (Median  = 12.2%) and AO (10.4%), compared to the TI (8.2%) and SC (6.7%). This was somewhat unexpected since TH17 cells have previously been reported to be enriched in the terminal ileum of mice [16], [17].

Figure 1
TH17 and TReg cells are enriched in the healthy human cecum.
Table 3
Cytokine staining panel.
Table 4
Nuclear antigen staining panel.

To determine if there were significant non-CD4+ sources of IL-17 such as innate lymphocytes [18], we modified our gating strategy to first select for all of the IL-17+ cells (Figure 2A) in the live cell gate. Overall, there was an almost equivalent number of total IL-17+ cells among the different regions examined, with a slight decrease in the number of IL-17+ cells in the SC compared to the TI, ICV and AO (Figure 2B). While a large majority of all the IL-17+ cells were CD3+ (Figure 2A), there were also some CD3-CD56- cells that were IL-17+ and these were significantly greater in numbers in the TI and SC (Figure 2C). This indicates a possible inverse relationship in the cecum between IL-17 production by CD3 CD56 cells and IL-17 production by CD3+ CD56 cells, which were predominantly CD4+ (Figure 2A & 2B). Whereas there were more TH17 cells in the cecum, there may be more innate lymphocytes producing IL-17 in the TI and the SC.

Figure 2
Non-CD4+ sources of IL-17 vary by biopsy location.

Previous studies of mucosal biopsies from HIV infected individuals have indicated that increased frequency of TH17 cells may be accompanied by reduced frequencies of TRegs because of the developmental link between these two populations [4]. However, when we assessed the frequency of CD4+CD25+FoxP3+ cells, we found that TRegs were also significantly enriched in the cecum (Figure 1D & E). The proportion of CD25+FoxP3+ cells in the CD4+ compartment was significantly higher in the ICV (8.8%) and AO (8.5%) compared to the TI (4.8%) and SC (6.3%) (Figure 1D & E). These results indicate that TH17/TReg balance is maintained across different locations of the healthy human intestine. Though TH17 and TRegs are enriched in the proximal colon, there were no significant differences in the regional variation of the ratio of TH17/TRegs in healthy individuals (Figure 1F).

Because it was not possible to standardize the quantity of tissue that was processed for isolating LPMCs, the results here are presented as proportional data to total CD4+ cells. Absolute cell counts could vary based on variation in the size of processed pinch biopsies. CD4+ cell viability was relatively uniform across all locations, with the exception being a slight increase in CD4+ viability from the appendiceal orifice compared to the sigmoid colon (Table 5).

Table 5
CD4+ viability among biopsy locations.

TH22 and IL-17 producing TReg cells are also enriched in the healthy human cecum

Recently, a population of CD4+ helper T cells that produces IL-22 but not IL-17 has been identified [10] and termed TH22 cells. We previously found that IL-22 producing CD4+ cells were associated with helminth infection and disease remission in a patient with ulcerative colitis [19]. However, the normal variation and distribution of TH22 cells across the intestine under baseline conditions is not known. In this study, we found that CD4+IL-22+IL17 T cells were also significantly elevated in the ICV (5.7%) and AO (5.9%), compared to the TI (3.1%) and the SC (3.6%), mirroring the results from TH17 and TReg cells (Figure 3A & 3B). Since IL-22 is important in controlling bacterial infections in the gut, such as Citrobacter rodentium [9], the enrichment of TH22 as well as TH17 cells in the cecum may indicate the presence of potentially pathogenic bacteria in this region that are actively restrained by the mucosal immune response. Additionally, IL-22 producing TH17 cells were also enriched in the cecum (Figure 3C).

Figure 3
TH22 and IL-17+FoxP3+ cells are enriched in the healthy human cecum.

Finally, we examined the distribution of IL-17 producing TRegs, which have been reported to be elevated in the inflamed mucosa of Crohn's disease patients [7] as well as ulcerative colitis patients [8]. We found that CD4+IL-17+FoxP3+ cells showed a similar pattern to TH17, TH22 and TRegs, being significantly elevated in the ICV (1.4%) and the AO (1.5%) compared to the TI (0.5%) and the SC (0.4%) (Figure 3D & 3E).

Together, these results from lamina propria CD4+ T cells suggest that there may be more immune activation in the cecum compared to both the small intestine (TI) and the distal colon (SC). However, only those CD4+ cell populations that have been reported to be important for mucosal homeostasis were enriched in the cecum. When we examined TH1 and TH2 populations that produce IFNγ and IL-4, there were no significant differences among the different sites that were biopsied in this study (Figure 4).

Figure 4
TH1 and TH2 lymphocyte populations do not vary by region.

Polycytokine production in lamina propria CD4+ T cells within the intestine

We next analyzed the different combinations of cytokines produced by CD4+ T cell populations among different regions of the gut. We utilized Boolean gate analysis (Figure 5A) to expand our five-cytokine measurements (IL-17, IL-22, IL-4, TNFα and IFNγ) into 32 unique functional combinations of cytokine-producing CD4+ cells. The pie charts shown in Figure 5B illustrate the averaged overall pattern of cytokine production among lamina propria CD4+ cells in the different regions of the gut. Each slice within the pie chart represents a specific combination of cytokine production (denoted in Figure 5C). Not surprisingly, the most common CD4+ cells are the ones not producing any of the five measured cytokines, followed by cells producing a combination of IFNγ and TNFα and then IFNγ and TNFα individually (Figure 5B, C). No significant differences in the composition of cytokine-producing CD4+ cells among the various biopsy locations were found using permutation testing in SPICE. However, we noted that populations of CD4+ cells producing IFNγ, TNFα, and IL-22 in combination, as well as TNFα and IL-22 together, appear to be more prevalent in the cecum compared to the terminal ileum and sigmoid colon.

Figure 5
Polycytokine producing CD4+ cells analyzed by Boolean gate analysis from different regions of the intestinal tract.

Transcriptional profiling analysis of biopsies from different regions of the intestine

To determine if the microenvironment from which we isolated lamina propria CD4+ cells may provide an explanation for the regional variation in the TH17, TH22 and TReg populations, we performed gene expression profiling experiments of paired pinch biopsies collected from the same regions that were analyzed by flow cytometry. RNA from a subset of matched samples (total N = 21, TI  = 6, ICV  = 5, AO  = 5, SC  = 5) from five subjects was isolated for DNA microarray analysis on the Agilent platform, in order to identify molecular signatures that may help to explain compositional differences in the CD4+ compartment. Unsupervised hierarchical clustering analysis was performed on 2,351 gene probes that were filtered to have a standard deviation of at least 1.0 between all 21 samples (Figure 6A). This analysis showed that the gene expression profiles of biopsies from the terminal ileum clustered very distinctly from biopsies of the cecum (including AO and ICV) and the sigmoid colon (SC). The appendiceal orifice and ileocecal valve were less distinct from each other and clustered together separately from the sigmoid colon and the terminal ileum. Principal component analysis of this dataset (Figure 6B) provided a similar picture, segregating the terminal ileum from the large intestine based on PC1, with the proximal colon (cecum, including AO and ICV) segregating from the sigmoid colon on PC2 (Figure 6B).

Figure 6
Transcriptional profiling analysis identifies regional variations of gene expression in the intestinal tract.

We then conducted a supervised analysis using multiclass statistical analysis of microarrays (SAM) to identify genes that were differentially expressed among regions of the intestine. 2,079 unique gene probes were identified at a False Discovery Rate (FDR) of 0% that varied significantly based on biopsy location (Figure 6C). Gene ontology (GO) analysis of this list of genes indicated that differences in lipid, protein, and carbohydrate metabolism varied most significantly among the different regions of the intestine that were biopsied (Figure 6D). Of note, 304 genes were grouped into the immunologic processes category (Table 6).

Table 6
Differential expression of gene probes involved in immunologic processes.

We were particularly interested in the differential expression of mucin genes among different regions of the gastrointestinal tract because of their important role in mucosal barrier function [20]. Furthermore, based on microarray analysis of an individual who treated his ulcerative colitis with Trichuris trichiura, we have hypothesized that increased mucus production could mitigate inflammatory pathology and bacterial attachment in the colon [19], [20]. We confirmed by real-time PCR on an expanded subset of samples (N = 40, TI  = 11, ICV  = 9, AO  = 10, SC  = 10) that MUC1 was most highly expressed in the sigmoid colon and least expressed in the terminal ileum, whereas MUC3 was most highly expressed in the terminal ileum and least expressed in the distal colon (Figure 7). MUC1 and MUC3 are membrane bound mucins. MUC1 is a tumor-associated molecule frequently overexpressed in carcinomas [21] and MUC3 is the major component of the glycocalyx of the small intestine [22]. Variants of MUC3 have previously been associated with inflammatory bowel diseases [23]. MUC5B had a similar expression profile to MUC1, being most elevated in the sigmoid colon (Figure 7), but is a secreted polymeric mucin that can be dysregulated in the lung of subjects with idiopathic pulmonary fibrosis [24].

Figure 7
Verification of gene expression by real-time PCR analysis of intestinal biopsy samples.

We also explored the differential expression of the peroxisome proliferator-activated receptor (PPAR) members of the nuclear hormone receptor superfamily because they are important regulators of inflammation [25]. We confirmed that PPARα was more highly expressed in the terminal ileum (Figure 7), whereas PPARγ was more highly expressed in the cecum (AO and ICV). This was surprising because PPARγ has been reported to inhibit TH17 differentiation [26] whereas here we find that the cecum has relatively more TH17 cells as well as higher expression of PPARγ. Perhaps the anti-inflammatory effects of PPARγ also require enrichment in the cecum in order to balance higher levels of immune activation. We performed additional two-class analysis by comparing the proximal colon to the distal colon and excluding the terminal ileum, with similar results (Figure 8).

Figure 8
Identification of gene probes differentially expressed between the cecum (including ileocecal valve and appendiceal orifice) and the sigmoid colon by two-way SAM analysis.

Consistent with the hypothesis that there is more bacterial mediated activation in the cecum, we confirmed elevated expression of the anti-microbial peptide DEFB1 (Figure 7). DEFB1 is the only defensin to be expressed in the uninflamed colon and certainly plays an important role in mucosal defense against microbes [27]. Although we speculated that the increased expression of DEFB1 and the enrichment of CD4+ T cells important in regulating mucosal barrier function may be driven by increased bacterial attachment to the intestinal wall in the cecum, we did not find significant differences in bacterial load present in these biopsies by qPCR analysis of bacterial specific ribosomal 16S DNA (Figure 9). Perhaps a more detailed deep sequencing analysis may identify specific differences in bacterial species that may be enriched on the intestinal wall of the cecum compared to other regions of the gastrointestinal tract.

Figure 9
Bacterial attachment does not vary by biopsy location.

Correlating transcriptional profiling data with frequency of TH17 and TReg cells

Having generated a combination of flow cytometry and transcriptional profiling datasets from paired biopsy samples, we sought to identify genes that have expression levels that are directly correlated with the frequency of lamina propria TH17 cells and TRegs in these healthy individuals (Figure 10). We defined the frequency of TH17 cells and TRegs obtained by flow cytometry as quantitative variable inputs to the statistical analysis of microarrays (SAM) algorithm in order to determine the strength of their relationship with gene expression values. Because of the relatively small number of samples, we used a conservative FDR of 0% as the cutoff for significance (Figure 10A–B and Table 7). For TH17 cells, we identified four gene probes that were positively correlated with TH17 cell frequency (including resistin (RETN)) and 12 gene probes that were negatively correlated with TH17 cell frequency (Figure 10A). Interestingly, many of the probes negatively associated with TH17 cell frequency encoded long non-coding RNA (lincRNA), for which the significance is unclear (Table 7). We did note with interest that trefoil factor 1 (TFF1) was among the most negatively associated genes with TH17 cell frequency. The positive association of RETN (r2 = 0.2275, P = <0.01) and negative association of TFF1 (r2 = 0.3308, P = <0.0001) with TH17 cell frequency were confirmed by RT-PCR analysis of additional biopsy samples (N = 40) from different regions of the intestine (Figure 10C). For TRegs (CD4+CD25+FoxP3+ cells), we identified 22 gene probes that were positively correlated, but none that were negatively associated with TReg frequency (Figure 10B). Of these genes, Fc receptor-like protein 5 (FCRL5) was of particular interest because there was a strong association to TReg frequency and a closely related FCRL family member was reported to be associated with TReg function [28]. We confirmed by RT-PCR analysis that FCRL5 (r2 = 0.3671, P = <0.001) was indeed positively associated with TReg frequency (Figure 10C).

Figure 10
Identification of RETN, TFF1 and FCRL5 as genes with expression levels that correlate with frequencies of TH17 and TReg cells.
Table 7
Gene probes associated with Th17 and T-regulatory cell populations.


In this study, we have systematically characterized regional differences of intestinal lamina propria CD4+ T cell populations by flow cytometry in a healthy population and identified gene expression patterns that correlate with their frequencies. We found the cecum to have significantly elevated frequencies of TH17, TH22, and TReg lymphocyte populations (but not TH1 or TH2 cells). Interestingly, these are the CD4+ subsets that are most important in regulating intestinal homeostasis. While TH17 cells are enriched in the terminal ileum in mice, we find here that the human cecum has a higher frequency of TH17 cells than does the ileum, reflecting important differences between mice and humans. Since intestinal mucosal CD4+ T cells are being increasingly studied under disease conditions (e.g. inflammatory bowel disease and HIV), it is important to rigorously investigate the baseline mucosal immune environment throughout the gut in healthy individuals. When mucosal biopsies are collected from different parts of the human intestine, there must be an awareness that inherent regional differences among CD4+ T cell populations are present in order to interpret study findings.

The results of our study are consistent with a previous histopathology study showing that the cecum is a site of inherent inflammation even in a normal healthy population without gastrointestinal symptoms [29]. Compared to the rectum, increased microscopic inflammation (especially greater cellularity of the lamina propria) in a significant proportion of cecal biopsies taken from endoscopically normal mucosa in healthy patients has been reported [29].

The cecum is generally considered to play a digestive role, being enlarged in herbivores to aid in the breakdown of cellulose [30]. However, there have been recent suggestions that it may have evolved in some species to perform an immunological function. In combination with the appendix, it has been proposed that the cecum could serve as a “safe house” for reconstituting commensal microbiota after an acute infectious diarrheal illness [30]. This hypothesis was partly driven by the finding that microbial biofilms are more abundant in the appendix than other parts of the human colon [13]. Secreted IgA and mucins in the cecum and appendix may support the growth of these microbial biofilms [13], [31]. More recently, it was reported that prior appendectomy was positively associated with increased risk of Clostridium difficile recurrence, suggesting that the appendix may play a protective role against infection. In contrast, previous appendectomy has been shown to inversely correlate with risk of colectomy, relapse rate, and extent of disease in ulcerative colitis (UC) patients in a series of case-control studies [32]. Prophylactic appendectomy has even been prospectively evaluated as a potential therapy for UC with promising results [11], [33]. Taken together, this literature suggests that microbial biofilms and immune activation in the cecum and appendix play a role in regulating homeostasis of intestinal microbiota, which could in turn impact homeostasis of the intestinal tissues. Based on this hypothesis, it would not be surprising that TH17, TH22, and TReg populations are enriched in the cecum to maintain an appropriate homeostasis between microbes and the intestinal mucosa.

Recently, innate lymphoid cells (ILCs) have emerged as an important non-CD4+ source of effector cytokines that may be particularly important at mucosal barrier surfaces [18]. IL-17 and IL-22 producing human ILCs are responsive to IL-23 signaling and could be important mediators of inflammatory bowel diseases [34]. Of additional interest was our observation that the increase in TH17 cells in the cecum (compared to the terminal ileum and sigmoid colon) was offset by having relatively fewer numbers of IL-17 producing CD3CD56 cells in this region. This inverse relationship raises the possibility of regulatory feedback between innate and adaptive sources of IL-17 in the healthy human intestinal tract.

We attempted to determine if the biopsies collected from the cecum had a greater bacterial load attached to the intestinal wall compared with those obtained from the terminal ileum and the sigmoid colon, but no significant differences were observed based on qPCR analysis of several bacterial ribosomal 16S DNA sequences (relative to host DNA). It is certainly conceivable that a deep sequencing analysis of bacterial ribosomal 16S units may lead to the identification of novel bacterial species or operational taxonomic units (OTUs) that are more abundant on the cecal wall compared to other parts of the intestine. Micro-heterogeneity between sample sites has been reported based on the very limited number of individuals who have been evaluated by deep sequencing studies of the colonic mucosa [35][37], but large variations in bacterial populations among intestinal regions has not been found. However, the cecum was not analyzed in detail in these studies. It would be extremely interesting to conduct deep sequencing analyses to determine the nature of the cecal microbiota attached to the mucosa using paired biopsy samples for which the gene expression profiles, as well as flow cytometry profiles of CD4+ T cell populations, is well characterized.

In a previous human study, gene expression profiling analysis was performed along the entire proximal-distal axis of the colon, but the terminal ileum was not included [38]. This study revealed two distinct patterns of transcript abundance along the proximal-distal axis of the large intestine. The colon was described as having a (i) dichotomous expression pattern consistent with its embryologic origins from both the midgut and the hindgut and hence segregating genes that are proximal or distal to a point that is two thirds the length of the transverse colon measured from the hepatic flexure and (ii) a gradual change in transcript levels from the cecum to the rectum, likely reflecting luminal flow and alterations in commensal microbiota. Our transcriptional profiling analysis of mucosal pinch biopsies confirms these results, with similar segregation of gene transcripts from both the proximal and distal colon and from the colon and terminal ileum. Additionally, we related transcriptional differences with the frequencies of CD4+ subsets along the intestine.

By correlating our flow cytometry analysis with gene expression profiling data from paired biopsy samples we discovered a positive relationship between the expression of resistin (RETN) and the frequency of TH17 cells. Resistin is a cytokine produced by adipose tissue and was originally discovered as a potential mediator of metabolic functions involved in insulin resistance [39]. More recently, it has been characterized as an inflammatory cytokine that is implicated in several pathologic intestinal conditions (e.g. colon cancer and inflammatory bowel disease) likely through induction of IL-1b, IL-6, IL-8, IL-12, TNFα, and other pro-inflammatory cytokines [40]. As a pro-inflammatory cytokine the positive association between the frequency of TH17 cells in the intestinal mucosa and expression levels of RETN is not surprising. PPARγ has been shown to regulate RETN activity in several studies [41], [42]. In this study we found that PPARγ expression and TH17 cell frequencies are both elevated in the human cecum, hence a relationship with RETN function is plausible. In addition, bacterial products like lipopolysaccharide (LPS) have been found to induce RETN expression in human and murine macrophages [43]. Future studies to establish a more mechanistic relationship between RETN and TH17 cells will need to be conducted before any conclusions can be made about the biological significance of this relationship.

We also found a negative relationship between the frequency of TH17 cells and the expression levels of TFF1. The trefoil factors are mucin-associated peptides associated with a number of human tissues, with TFF1 and TFF2 primarily located in the gastric mucosa and TFF3 predominantly present in the mucus cells of the small and large intestine [44]. Up-regulation of all three TFF members occurs at sites of mucosal injury and has been observed in patients with peptic ulcer disease and inflammatory bowel disease [44], [45]. TFF1 plays a critical role in mucosal protection and repair, with loss of TFF1 being associated with NF-κB-mediated inflammation and gastric carcinogenesis [46]. Based on these observations, it was surprising to observe a negative relationship between the frequencies of TH17 cells and TFF1, since both factors could be important for maintaining intestinal homeostasis. One possibility could be that the anti-microbial effects of TFF1 are acting through an independent pathway from TH17 cells. Hence, when bacterial loads are controlled through a TFF1 mediated pathway, fewer TH17 cells are required. This hypothesis could be tested further through the careful localization of TFF1 expression and presence of TH17 cells by immunohistochemistry of the intestinal tissues.

Finally, we found that TReg frequencies were positively associated with expression of FCRL5 (CD307). FCRL3, a closely related FCRL family member, is highly expressed on dysfunctional TRegs that express high levels of PD-1 and have a memory phenotype [28]. While FCRL5 has mostly been characterized in B cells and B cell lymphomas [47], [48], polymorphisms have also been reported to be associated with autoimmune diseases such as ankylosing spondylitis [49], suggesting an immunoregulatory role [47]. The relationship between FCRL5 and TReg cells in regulating intestinal homeostasis warrants further investigation.

This study has important limitations. The majority of the enrolled subjects were older black men and so their mucosal environment may not be representative of younger patients in a disease state. Furthermore, complete colonoscopies requiring a preparative purge were performed to obtain biopsies from the cecum, a feature that may impact the analysis of the intestinal microenvironment. While the pinch biopsy samples obtained were approximately equal in size from all locations and from all subjects, we did not directly measure the absolute numbers of cells per gram of pinch biopsy tissue from each location. Importantly, CD4+ viability was relatively similar independent of biopsy location. Lastly, we recognize that differences in gene expression profiles of the pinch biopsies may be caused by heterogeneity of cellular populations and cellular density between samples. Nonetheless, this study is a step towards understanding location-specific variations in lamina propria CD4+ T cell populations in healthy individuals. This information may provide a basis for comparison when characterizing disease conditions that have characteristic distribution patterns along the intestinal tract, such as Crohn's disease and ulcerative colitis.


Ethics statement

New York Harbor Veterans Affairs Hospital Institutional Review Board approval was obtained before enrolling subjects in the study. Written informed consent was received from all participants.

Research subjects

Consecutive subjects over the age of 50 who were at an average risk for colon cancer presented for screening colonoscopy and were enrolled in the study. Subjects were excluded who required endoscopy for an indication other than screening (e.g. family history of colon cancer, iron deficiency anemia, or hematochezia), were positive for human immunodeficiency virus (HIV), or who had absolute or relative contraindications to acquisition of biopsies for research purposes at the time of colonoscopy (e.g. systemic anticoagulation at the time of the procedure).

Biopsy acquisition protocol

Six to eight pinch biopsies were obtained at colonoscopy from the terminal ileum (TI), the ileocecal valve (ICV), the appendiceal orifice (AO), and the sigmoid colon defined as 20 centimeters from the anal verge (SC) using sterile cold biopsy forceps. Not every location was biopsied in all subjects due to technical factors (e.g. a tortuous colon did not permit terminal ileum intubation). The mucosa was directly observed and irrigated after biopsy acquisition to ensure resolution of bleeding. One biopsy from each location was snap-frozen for RNA extraction in Trizol reagent (Invitrogen). The remaining biopsies were placed in complete RPMI containing 10% fetal calf serum, 0.05 mM 2-Mercaptoethanol, and penicillin/streptomycin/glutamine (Invitrogen).

Isolation of lamina propria mononuclear cells

Biopsies were digested at 37°C for 1 hour in 100units/mL of collagenase Type VIII (Sigma) and 150 μg/mL DNase (Sigma) in complete RPMI. Cells were filtered through a 50 micron filter, washed with 5 mL 1X PBS, and pelleted. Cells were then resuspended in 40% Percoll (GE Healthcare), under-layered with 80% Percoll, and centrifuged at 2,200 rpm for 20 minutes at room temperature. Mononuclear cells were collected at the interface and used for subsequent flow cytometric analyses.

FACS staining

Cells were stimulated with phorbol 12- myristate 13-acetate (PMA) and ionomycin for 4 hours at 37°C in the presence of brefeldin A (GolgiPlug, BD). Cells were subsequently divided for staining in one of two panels: (1) a “cytokine” panel whereby cells were stained with anti-CD3, anti-CD4, anti-CD8, and anti-CD56 and fixed in 4% paraformaldehyde in PBS and (2) a “nuclear antigen” panel whereby cells were stained with anti-CD3, anti-CD4, anti-CD8, anti-CD56, and anti-CD25 surface markers using the Fix/Perm Buffer Kit (eBioscience) for fixation and permeabilization. Live/Dead (aqua) viability dye (Invitrogen) was added to each panel. Cells in the “cytokine” panel were permeabilized and stained with an intracellular cytokine panel for interleukin (IL)-4, IL-17, IL-22, interferon-γ (IFNγ), and tumor necrosis factor-α (TNFα); cells in the “nuclear antigen” panel were stained with forkhead box P3 (FoxP3). Simultaneous multi-color flow cytometry was performed (BD LSR II). Results were analyzed in Flowjo (Treestar, Inc.) and statistical analysis was performed using Prism (GraphPad Software, Inc.)

Boolean gate analysis of flow cytometric data

Five cytokine-producing CD4+ cell populations were analyzed in Flowjo using Boolean gates in order to calculate 32 possible cytokine populations. Data was exported to Simplified Presentation of Incredibly Complex Evaluations (SPICE) and filtered at a 2% cutoff to simplify the representation of the data (

Determination of bacterial attachment

DNA was isolated from intestinal pinch biopsies stored in Trizol using the DNeasy Blood and Tissue Kit (Qiagen) according to the manufacturer's instructions. After a chloroform purification and ethanol extraction step, DNA was probed with Taqman probes designed for bacterial genes of interest (Applied Biosystems). Bacterial probes were selected for universal bacteria 16S, Clostridiales, Bacteroides, Prevotella, and Fusobacterium as previously described [50][53]. The RNase P copy number assay was utilized as a basis to compare bacterial DNA content to host (human) DNA content (Applied Biosystems) by performing a logarithmic ratio of the cycle thresholds obtained for bacterial and host DNA.

Transcriptional profiling and real-time PCR analysis of intestinal biopsies

Complementary DNA (cDNA) was reverse transcribed from RNA isolated from intestinal pinch biopsies according to manufacturer's instructions (Agilent Technologies). Cyanine 3-labeled, linearly amplified complementary RNA (cRNA) was then synthesized, purified, hybridized to microarray slides, and scanned using the High Resolution C Scanner according to the manufacturer's instructions (Agilent Technologies). The raw data was then uploaded to Microsoft Excel, where it was log-transformed quantile-normalized and median centered. Expression profiling data were filtered at a standard deviation of 1.0 before undergoing unsupervised hierarchical clustering analysis in Cluster (Eisenlab). Results were then visualized with Java Treeview. Principal component analysis (PCA) was performed on the gene expression parameters using Cluster to generate eigenvalues, and the resulting datasets were further compiled and plotted on Excel. Filtered data sets were also analyzed for statistically significant genes (either through unpaired two-way comparison or multiclass analysis) with the Statistical Analysis of Microarrays (SAM) software version 2.23 A ( Correlations between gene expression data and flow cytometric parameters were performed using quantitative analysis in SAM. Gene ontology (GO) and pathway analyses were performed with Protein Analysis Through Evolutionary Relationships (PANTHER) software (

Real-time quantitative PCR of intestinal biopsies

1μg of RNA from each sample was reverse-transcribed using SuperScript III Reverse Transcriptase (Invitrogen) and the resulting cDNA was used for quantitative real-time PCR with Taqman probes ordered directly from the manufacturer for the following genes of interest: DEFB1 (Hs00608345_m1), FCRL5 (Hs01070204_m1), MUC1 (Hs00159357_m1), MUC3 (Hs03649367_mH), MUC5 (Hs00861588_m1), PPARA (Hs00947539_m1), PPARG (Hs01115513_m1), TFF1 (Hs00907239_m1), and RETN (Hs00220767_m1) (Applied Biosystems). All cycle threshold values were normalized to GAPDH values. No significant differences in GAPDH expression were observed among the biopsy sites (data not shown). Data was analyzed with the t test using Prism 5.0 (GraphPad Software).

Statistical analysis

Statistical analysis was performed using Prism 5.0 (GraphPad Software). The two-tailed Mann Whitney non-parametric t test was used to assess statistical significance for all samples.


We acknowledge the patients who graciously participated in this study and the medical staff of the New York Harbor Veterans Affairs Hospital who assisted in the execution of the biopsy protocol. We thank Charlie Kim, Ph.D. in the Division of Experimental Medicine at the University of California, San Francisco for his expert assistance with the microarray analysis. We thank Martin Blaser, M.D. and Dan Littman, M.D. at the New York University School of Medicine for their suggestions throughout this project.


Competing Interests: The authors have declared that no competing interests exist.

Funding: This work was supported by startup funds to Dr. P'ng Loke from the New York University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474:298–306. [PubMed]
2. Honda K, Littman DR. The Microbiome in Infectious Disease and Inflammation. Annu Rev Immunol 30. 2011. [PubMed]
3. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140:1756–1767. [PubMed]
4. Hartigan-O'Connor DJ, Hirao LA, McCune JM, Dandekar S. Th17 cells and regulatory T cells in elite control over HIV and SIV. Curr Opin HIV AIDS. 2011;6:221–227. [PubMed]
5. Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity. 2009;30:646–655. [PubMed]
6. Weaver CT, Hatton RD. Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol. 2009;9:883–889. [PubMed]
7. Hovhannisyan Z, Treatman J, Littman DR, Mayer L. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology. 2011;140:957–965. [PMC free article] [PubMed]
8. Kryczek I, Wu K, Zhao E, Wei S, Vatan L, et al. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J Immunol. 2011;186:4388–4395. [PubMed]
9. Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol. 2011;12:383–390. [PubMed]
10. Trifari S, Spits H. IL-22-producing CD4+ T cells: middle-men between the immune system and its environment. Eur J Immunol. 2010;40:2369–2371. [PubMed]
11. Cosnes J, Carbonnel F, Beaugerie L, Blain A, Reijasse D, et al. Effects of appendicectomy on the course of ulcerative colitis. Gut. 2002;51:803–807. [PMC free article] [PubMed]
12. Im G, Modayil R, Lin C, Geier S, Katz D, et al. The appendix may protect against Clostridium difficile recurrence. Clinical gastroenterology and hepatology. 2011;9:1072–1077. [PubMed]
13. Randal Bollinger R, Barbas A, Bush E, Lin S, Parker W. Biofilms in the large bowel suggest an apparent function of the human vermiform appendix. Journal of theoretical biology. 2007;249:826–831. [PubMed]
14. Matsushita M, Uchida K, Okazaki K. Role of the appendix in the pathogenesis of ulcerative colitis. Inflammopharmacology. 2007;15:154–157. [PubMed]
15. Heitman SJ RP, Hilsden RJ, Manns BJ, Rostom A, Hemmelgarn BR. Prevalence of adenomas and colorectal cancer in average risk individuals: a systemic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:1272–1278. [PubMed]
16. Esplugues E, Huber S, Gagliani N, Hauser AE, Town T, et al. Control of TH17 cells occurs in the small intestine. Nature. 2011;475:514–518. [PMC free article] [PubMed]
17. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139:485–498. [PMC free article] [PubMed]
18. Spits H CT. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol. 2012;30:647–675. [PubMed]
19. Broadhurst MJ, Leung JM, Kashyap V, McCune JM, Mahadevan U, et al. IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient. Sci Transl Med. 2010;2:60ra88. [PubMed]
20. Wolff M, Broadhurst M, Loke P'ng. Helminthic therapy: improving mucosal barrier function. Trends in parasitology. 2012;28:187–194. [PubMed]
21. Bafna S, Kaur S, Batra SK. Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene. 2010;29:2893–2904. [PMC free article] [PubMed]
22. Kim YS, Ho SB. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep. 2010;12:319–330. [PMC free article] [PubMed]
23. Kyo K, Muto T, Nagawa H, Lathrop GM, Nakamura Y. Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease. J Hum Genet. 2001;46:5–20. [PubMed]
24. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med. 2011;364:1503–1512. [PMC free article] [PubMed]
25. Glass CK, Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev Immunol. 2010;10:365–376. [PubMed]
26. Klotz L, Burgdorf S, Dani I, Saijo K, Flossdorf J, et al. The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J Exp Med. 2009;206:2079–2089. [PMC free article] [PubMed]
27. Wehkamp J, Koslowski M, Wang G, Stange EF. Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease. Mucosal Immunol. 2008;1:S67–74. [PubMed]
28. Swainson LA, Mold JE, Bajpai UD, McCune JM. Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. J Immunol. 2010;184:3639–3647. [PMC free article] [PubMed]
29. Paski S, Wightman R, Robert M, Bernstein C. The importance of recognizing increased cecal inflammation in health and avoiding the misdiagnosis of nonspecific colitis. The American journal of gastroenterology. 2007;102:2294–2299. [PubMed]
30. Smith HF, Fisher RE, Everett ML, Thomas AD, Bollinger RR, et al. Comparative anatomy and phylogenetic distribution of the mammalian cecal appendix. J Evol Biol. 2009;22:1984–1999. [PubMed]
31. Palestrant D, Holzknecht Z, Collins B, Parker W, Miller S, et al. Microbial biofilms in the gut: visualization by electron microscopy and by acridine orange staining. Ultrastructural pathology. 2004;28:23–27. [PubMed]
32. Gardenbroek TJ, Eshuis EJ, Ponsioen CI, Ubbink DT, D'Haens GRAM, et al. The effect of appendectomy on the course of ulcerative colitis: a systematic review. Colorectal Disease: no-no. 2011. [PubMed]
33. Bolin T, Wong S, Crouch R, Engelman J, Riordan S. Appendicectomy as a therapy for ulcerative proctitis. The American journal of gastroenterology. 2009;104:2476–2482. [PubMed]
34. Geremia A, Arancibia-Crcamo C, Fleming MPP, Rust N, Singh B, et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. The Journal of experimental medicine. 2011;208:1127–1133. [PMC free article] [PubMed]
35. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635–1638. [PMC free article] [PubMed]
36. Wang M, Ahrne S, Jeppsson B, Molin G. Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol Ecol. 2005;54:219–231. [PubMed]
37. Hong PY, Croix JA, Greenberg E, Gaskins HR, Mackie RI. Pyrosequencing-based analysis of the mucosal microbiota in healthy individuals reveals ubiquitous bacterial groups and micro-heterogeneity. PLoS One. 2011;6:e25042. [PMC free article] [PubMed]
38. LaPointe L, Dunne R, Brown G, Worthley D, Molloy P, et al. Map of differential transcript expression in the normal human large intestine. Physiological genomics. 2008;33:50–64. [PubMed]
39. Schwartz DR, Lazar MA. Human resistin: found in translation from mouse to man. Trends Endocrinol Metab. 2011;22:259–265. [PMC free article] [PubMed]
40. Tiaka E, Manolakis A, Kapsoritakis A, Potamianos S. The implication of adiponectin and resistin in gastrointestinal diseases. Cytokine & growth factor reviews. 2011;22:109–119. [PubMed]
41. Patel L, Buckels A, Kinghorn I, Murdock P, Holbrook J, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochemical and biophysical research communications. 2003;300:472–476. [PubMed]
42. Steppan C, Lazar M. The current biology of resistin. Journal of internal medicine. 2004;255:439–447. [PubMed]
43. Lu S-C, Shieh W-Y, Chen C-Y, Hsu S-C, Chen H-L. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS letters. 2002;530:158–162. [PubMed]
44. Vestergaard EM, Brynskov J, Ejskjaer K, Clausen JT, Thim L, et al. Immunoassays of human trefoil factors 1 and 2: measured on serum from patients with inflammatory bowel disease. Scandinavian journal of clinical & laboratory investigation. 2004;64:146–156. [PubMed]
45. Rio MC, Chenard MP, Wolf C, Marcellin L, Tomasetto C, et al. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology. 1991;100:375–379. [PubMed]
46. Soutto M, Belkhiri A, Piazuelo MB, Schneider B, Peng D, et al. Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans. The Journal of clinical investigation. 2011;121:1753–1767. [PMC free article] [PubMed]
47. Ehrhardt GR, Cooper MD. Immunoregulatory roles for fc receptor-like molecules. Curr Top Microbiol Immunol. 2011;350:89–104. [PubMed]
48. Davis RS. Fc receptor-like molecules. Annu Rev Immunol. 2007;25:525–560. [PubMed]
49. Tang X, Pan F, Xia G, Liao F, Ge R, et al. A single-nucleotide polymorphism marker within the FCRL5 gene and HLA-B27 positive Han Chinese ankylosing spondylitis patients. Tissue Antigens. 2009;74:314–316. [PubMed]
50. Bouskra D, Brzillon C, Brard M, Werts C, Varona R, et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature. 2008;456:507–510. [PubMed]
51. Ott S, Musfeldt M, Ullmann U, Hampe J, Schreiber S. Quantification of intestinal bacterial populations by real-time PCR with a universal primer set and minor groove binder probes: a global approach to the enteric flora. Journal of clinical microbiology. 2004;42:2566–2572. [PMC free article] [PubMed]
52. Wolff D, Staehle HJ, Wolff B. Amplification of minute amounts of oral bacterial DNA for real-time quantitative PCR analysis. Caries Research. 2010;44:498–504. [PubMed]
53. Elinav E, Strowig T, Kau A, Henao Mejia J, Thaiss C, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145:745–757. [PMC free article] [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science